WORCESTER, Mass., Nov. 23, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. (www.antigenexpress.com), Generex’s wholly-owned immunotherapeutics subsidiary, made a presentation on the Company’s H1N1 Swine Flu program at a national symposium on influenza. The meeting, Influenza Congress USA 2009, was held in Washington, D.C last week. Representatives from key US and international agencies, policy makers, major pharmaceutical companies and biotechnology were in attendance.
